TrialHepatology international2026
Tolvaptan for hyponatremia in patients with cirrhosis: a post hoc subgroup analysis of a multicenter, randomized, double-blind, placebo-controlled trial.
Yu Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.